Modesa 2 In 1 Dandruff
FDA Label NDC 40104-436

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Ningbo Pulisi Daily Chemical Products Co., Ltd. for the product Modesa 2 In 1 Dandruff (NDC 40104-436). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, inactive ingredient, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Active Ingredient                                               Purpose

Pyrithione Zinc             1.00%                            Anti-dandruff

Otc - Purpose

Help prevent to treat flakes, itch, irritation, oilness or dryness caused by dandruff.

Otc - Keep Out Of Reach Of Children

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222)right away.
Avoid contact with eyes, if contact occurs rinse eyes with plenty of water.

Indications & Usage

wet hair, squeeze small amount to palm, lather, rinse well for best results use at least twice a week or as directed by a doctor.

Warnings

For external use only.

Stop use and ask a doctor if Condition worsens or does not improve after regular use as directed.

Dosage & Administration

small amount to palm, or as directed by a doctor.

Inactive Ingredient

water, sodium laureth sulfate, cocamide MEA, glycol distearate, acrylates copolymer, sodium chloride, methylchloroisothiazolinone, methylisothiazolinone, fragrance, guar hydroxypropyltrimonium chloride, zinc sulfate, dimethicone, cetyl alcohol, benzyl alcohol, sodium hydroxide, citric acid, sodium benzoate, FD&C blue no. 1, D&C red no. 33.

* Please review the disclaimer below.